2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow orforglipron: new trials by email Literature Review of orforglipron trials Research Report on orforglipron
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities LY3502970, Placebo - Obesity, Overweight and Obesity | Phase 2 | Completed | Eli Lilly and Company | 272 | 2021-09-29 | 2023-09-13 |
| A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus LY3502970, Dulaglutide, Placebo - Type 2 Diabetes | Phase 2 | Completed | Eli Lilly and Company | 383 | 2021-09-15 | 2023-10-17 |
Diabetes Mellitus, Type 2 (1) · Obesity (1) · Overweight (1)
Hungary (2) · Puerto Rico (2) · United States (2) · Canada (1) · Poland (1) · Slovakia (1)